PF Foundation Patient Registry Opening to Those With Secondary PH

PF Foundation Patient Registry Opening to Those With Secondary PH

283760

PF Foundation Patient Registry Opening to Those With Secondary PH

United Therapeutics is now among the leading sponsors of the Pulmonary Fibrosis Foundation (PFF) Registry, a research data resource for pulmonary fibrosis (PF) that is expanding to include pulmonary hypertension (PH) associated with PF, the foundation announced. Pulmonary hypertension that develops during the course of PF (characterized by scarring of lung tissue) negatively affects the well-being and survival of PF patients. People with PH associated with PF also have no therapies approved by the U.S. Food and Drug…

You must be logged in to read/download the full post.